Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study

Int J Cancer. 1999 May 31;81(5):695-9. doi: 10.1002/(sici)1097-0215(19990531)81:5<695::aid-ijc4>3.0.co;2-w.

Abstract

We performed a case-control study to evaluate the risk of hepatocellular carcinoma (HCC) for hepatitis C virus (HCV) infection. A total of 305 newly diagnosed HCC cases (80% males) and 610 subjects (81% males) unaffected by clinically evident hepatic disease admitted to the 2 main hospitals in Brescia, North Italy, were recruited as cases and controls, respectively. Among the 122 HCC cases positive for HCV RNA, genotype 1b was found in 83 patients (68%), genotype 2 in 36 (29.5%) and genotype 1a in 3 (2.5%). Among the controls, 15 were infected with genotype 1b and 15 with type 2. Analysis of HCV envelope 1 nucleotide sequence among 25 cases and 8 controls infected with genotype 2 showed subtype 2c in 96% of cases and in all controls, and subtype 2a in 1 HCC case. The odds ratio (OR) for HCV RNA positivity adjusted for hepatitis B virus (HBV) markers and alcohol intake was 26.3 [95% confidence interval (CI): 15.8-44], and it was higher for genotype 1b (OR = 34.2) than type 2 (OR = 14.4). The OR for HCV RNA was 35.6 (95% CI: 14.5-87.1) when the HBV markers were all negative and 132 (15.3-890) when HBsAg positivity was present; the OR was 26.1 (95% CI: 12.6-54.0) among subjects with alcohol intake of 0-40 g/day and increased to 62.6 (23.3-168) and 126 (42.8-373) with an alcohol intake of 41-80 and >80 g/day, respectively. In conclusion, synergism was found between HCV infection and HBV infection and alcohol intake in causing HCC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Alcohol Drinking / adverse effects*
  • Antibodies, Viral / blood
  • Antigens, Viral / blood
  • Carcinoma, Hepatocellular / epidemiology
  • Carcinoma, Hepatocellular / etiology*
  • Case-Control Studies
  • Female
  • Genotype
  • Hepacivirus / genetics
  • Hepacivirus / isolation & purification*
  • Hepatitis B / blood
  • Hepatitis B / complications
  • Hepatitis B / epidemiology
  • Hepatitis B virus / isolation & purification*
  • Hepatitis C / blood
  • Hepatitis C / complications*
  • Hepatitis C / epidemiology
  • Humans
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / etiology*
  • Male
  • Middle Aged
  • Odds Ratio
  • RNA, Viral / blood
  • Risk Factors
  • Seroepidemiologic Studies
  • Sex

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • RNA, Viral

Associated data

  • GENBANK/AF142385
  • GENBANK/AF142386
  • GENBANK/AF142387
  • GENBANK/AF142388
  • GENBANK/AF142389
  • GENBANK/AF142390
  • GENBANK/AF142391
  • GENBANK/AF142392
  • GENBANK/AF142393
  • GENBANK/AF142394
  • GENBANK/AF142395
  • GENBANK/AF142396
  • GENBANK/AF142397
  • GENBANK/AF142398
  • GENBANK/AF142399
  • GENBANK/AF142400
  • GENBANK/AF142401
  • GENBANK/AF142402
  • GENBANK/AF142403
  • GENBANK/AF142404